Rossi et al. (2011)
Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| MZL | 4 | 1 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 4
New Tier 1, MZL Tier 1, 4
This study, New Tier 2, 1
New Tier 2, MZL Tier 2, 1
This study, New Tier 3, 0
New Tier 3, MZL Tier 3, 0
All other MZL studies, MZL Tier 1, 38
All other MZL studies, MZL Tier 2, 73
All other MZL studies, MZL Tier 3, 0
Novel genes reported in this study
Tier 1
| New gene | MZL tier |
|---|---|
| BIRC3 | 1 |
| MAP3K14 | 1 |
| TNFAIP3 | 1 |
| TRAF3 | 1 |
Tier 2
| New gene | MZL tier |
|---|---|
| IKBKB | 2 |
Details
Rossi, Davide, Silvia Deaglio, David Dominguez-Sola, Silvia Rasi,
Tiziana Vaisitti, Claudio Agostinelli, Valeria Spina, et al. 2011.
“Alteration of Birc3 and Multiple Other NF-κB Pathway Genes in Splenic Marginal Zone
Lymphoma.” Blood 118 (18): 4930–34. https://doi.org/10.1182/blood-2011-06-359166.


